View Alert


Originator: DHSC & NHS England and Improvement: Supply disruption alert

 
Issue date: 20-Dec-2019 12:18:39

Action by recipients:
  • Care Trusts
  • Mental Health Trusts
  • Specialists Trusts
  • NHS Regional Offices
  • Learning Disabilities Trusts
  • Mental Health & Social Care Trusts
  • Ambulance Trusts
  • Mental Health & Learning Disabilities
  • Acute Trusts
  • Community Trusts

Information to recipients:
  • MHRA (Medicines) Drug Alerts (Various Recipients)
  • Other contacts
  • Independent Healthcare Providers (registered with CAS)
  • Clinical Commissioning Groups
  • Social Care Providers (registered with CAS)
  • MHRA (Medicines) Drug Alerts - Non-NHS Recipients
  • GP - Locum
  • NHS 111 and Out of hours providers
  • GP Practices
  • DHSC Supply Disruption - Medicines

Action category: Action

Title: Ranitidine: all formulations. Supply disruption alert - second update

Broadcast content: This alert provides a further update on the supply status of ranitidine products, including advice on the management of affected patients.

This is an update to SDA/2019/005(U). CAS Liaison Officers should close off SDA/2019/005(U) if it is still open, noting in the comments box that it has been superceded by this alert.


Additional information: NHS England and Improvement Regional Offices: please cascade this alert to Community Pharmacy.

Alert reference: SDA/2019/005(U2)

Action underway deadline: 27-Dec-2019

Action complete deadline: 20-Mar-2020

Attachments:

Contact our helpdesk

Email: safetyalerts@mhra.gov.uk

Medicines and Healthcare products Regulatory Agency